437 related articles for article (PubMed ID: 7511188)
1. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
2. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.
Wong SY; Purdie AT; Han P
Am J Pathol; 1992 Jun; 140(6):1473-82. PubMed ID: 1351369
[TBL] [Abstract][Full Text] [Related]
4. Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors.
Roth JJ; Reiver DM; Granick MS; Rothman VL; Nicosia RF; Tuszynski GP
Histol Histopathol; 1997 Oct; 12(4):1013-8. PubMed ID: 9302563
[TBL] [Abstract][Full Text] [Related]
5. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
6. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
Yabkowitz R; Dixit VM
Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
8. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.
Hosokawa T; Muraishi A; Rothman VL; Papale M; Tuszynski GP
Oncol Res; 1993; 5(4-5):183-9. PubMed ID: 8305744
[TBL] [Abstract][Full Text] [Related]
9. Localization of thrombospondin in hepatocellular carcinoma.
Hayashi K; Kurohiji T; Shirouzu K
Hepatology; 1997 Mar; 25(3):569-74. PubMed ID: 9049200
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
11. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
Wakiyama T; Shinohara T; Shirakusa T; John AS; Tuszynski GP
Histol Histopathol; 2001 Apr; 16(2):345-51. PubMed ID: 11332689
[TBL] [Abstract][Full Text] [Related]
12. Cysteine proteinase inhibitor cystatin A in breast cancer.
Cancer Res; ; . PubMed ID: 9458085
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
